Baxter International, Inc. (BAX)
25.46
-0.54
(-2.08%)
USD |
NYSE |
Sep 01, 16:00
25.46
0.00 (0.00%)
After-Hours: 20:00
Baxter International Research and Development Expense (Annual) : 503.00M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 503.00M |
| December 31, 2024 | 510.00M |
| December 31, 2023 | 508.00M |
| December 31, 2022 | 599.00M |
| December 31, 2021 | 529.00M |
| December 31, 2020 | 495.00M |
| December 31, 2019 | 542.00M |
| December 31, 2018 | 621.00M |
| December 31, 2017 | 613.00M |
| December 31, 2016 | 540.00M |
| December 31, 2015 | 589.00M |
| December 31, 2014 | 608.00M |
| December 31, 2013 | 1.118B |
| December 31, 2012 | 1.128B |
| December 31, 2011 | 946.00M |
| December 31, 2010 | 881.00M |
| December 31, 2009 | 917.00M |
| December 31, 2008 | 849.00M |
| December 31, 2007 | 699.00M |
| December 31, 2006 | 614.00M |
| December 31, 2005 | 533.00M |
| December 31, 2004 | 517.00M |
| December 31, 2003 | 553.00M |
| Date | Value |
|---|---|
| December 31, 2002 | 501.00M |
| December 31, 2001 | 427.00M |
| December 31, 2000 | 379.00M |
| December 31, 1999 | 332.00M |
| December 31, 1998 | 379.00M |
| December 31, 1997 | 392.00M |
| December 31, 1996 | 340.00M |
| December 31, 1995 | 345.00M |
| December 31, 1994 | 343.00M |
| December 31, 1993 | 337.00M |
| December 31, 1992 | 317.00M |
| December 31, 1991 | 289.00M |
| December 31, 1990 | 261.00M |
| December 31, 1989 | 245.00M |
| December 31, 1988 | 238.00M |
| December 31, 1987 | 199.00M |
| December 31, 1986 | 203.00M |
| December 31, 1985 | 128.00M |
| December 31, 1984 | 110.91M |
| December 31, 1983 | 107.99M |
| December 31, 1982 | 92.64M |
| December 31, 1981 | 67.78M |
| December 31, 1980 | 57.20M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Becton, Dickinson & Co. | 1.265B |
| DexCom, Inc. | 594.90M |
| Boston Scientific Corp. | 2.052B |
| West Pharmaceutical Services, Inc. | 74.30M |
| Abbott Laboratories | 2.889B |